Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy.
about
Common antiepileptic drugs in pregnancy in women with epilepsyTreatment for epilepsy in pregnancy: neurodevelopmental outcomes in the childCommon antiepileptic drugs in pregnancy in women with epilepsyPattern of antiepileptic drug-induced cell death in limbic regions of the neonatal rat brainThe longer term outcome of children born to mothers with epilepsyA clinical study of 57 children with fetal anticonvulsant syndromesMood stabilizers in pregnancy and lactationNeurodevelopmental effects of fetal antiepileptic drug exposureAn Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment OutcomesEnsuring the safe and effective use of medications during pregnancy: planning and prevention through preconception careAdditional educational needs in children born to mothers with epilepsyOutcome of children born to epileptic mothers treated with carbamazepine during pregnancyPreconception and prenatal environmental factors associated with communication impairments in 9 year old children using an exposome-wide approachImpact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.Pregnancy outcome and neurodevelopment of children exposed in utero to psychoactive drugs: the Motherisk experience.Treatment with a monoclonal antibody against methamphetamine and amphetamine reduces maternal and fetal rat brain concentrations in late pregnancy.Long-term consequences after exposure to antiepileptic drugs in utero.Antiepileptic drugs in women with epilepsy during pregnancyData sources on drug safety evaluation: a review of recent published meta-analyses.Treatment guidelines for depression in pregnancy.Update on new developments in the study of human teratogens.Late cognitive effects of early treatment with phenobarbital.Managing bipolar disorder during pregnancy: weighing the risks and benefits.Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest?Teratogen-induced limb defects.Anti-epileptic drugs in pregnancy: current safety and other issues.Prescription drugs and pregnancy.Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth.Developmental neuropathology of environmental agents.Cognitive outcomes of prenatal antiepileptic drug exposure.Psychiatric disorders during pregnancy.Neuropathological sequelae of developmental exposure to antiepileptic and anesthetic drugs.Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): teratogenesis and perinatal outcomes: report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment SubcomNeurological and psychiatric sequelae of developmental exposure to antiepileptic drugs.Cognitive/behavioral teratogenetic effects of antiepileptic drugs.Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy?Teratogenicity of antiepileptic medications.Prenatal exposure to carbamazepine reduces hippocampal and cortical neuronal cell population in new-born and young mice without detectable effects on learning and memory.Antiepileptic drug use in women of childbearing age.
P2860
Q24187306-ACC42D03-F336-490F-8537-AEBA2AF0676BQ24193032-2CC205EA-1860-41C0-9664-029DED50C321Q24246634-B227D504-F7F3-4BA4-93A2-80E223736E6EQ24632453-61EB7984-9B87-489E-898B-6CA14EDD1222Q24671544-8EC2D7AC-1A22-45CB-A368-10C09E05523AQ24681122-946B73FF-C514-4CFD-8E4A-88AAFE7B8598Q26795394-30BBA5D8-9283-4A16-9FB1-12D5D2611318Q28080703-A91A5218-05E0-49BB-8F57-75FA4A3A82ACQ28081205-BEDC8914-12B0-4057-BC7D-634E4FA0545FQ28199588-15477216-7144-4421-A818-CE638F11DBC2Q28345141-1CACAE3A-7D5E-4DB6-8136-C15A16DC2C73Q28379440-DA4C7EFA-B884-460A-8333-0433C8F4B5F3Q28543797-8A76BE73-DAFC-434B-8AFD-6774F1B62822Q30443028-5571DB27-140C-43F0-BFE1-7FBD8E5A1620Q33921923-FAA917E9-1057-432A-AE09-B528C681A90FQ33942970-69C44FA5-3439-4E16-A0A4-6455B881FF2AQ33949257-8E9B354C-C2AC-458A-8020-D09518D42E19Q33949402-91A74FAC-D7AE-4338-907A-D016C5439386Q34057069-C0EF0A11-8EDE-49DF-9D32-D3F6CC4DD546Q34123236-F7583523-C44D-4EF4-B0DC-0440D0157830Q34123327-36A459A1-FF66-44B8-9169-A6AE1E86C407Q34504315-A2C0647B-400F-469A-B393-42072A4F9EB7Q34708409-A18D4A33-4280-4E65-9BAC-05E02AE2897EQ34905287-4B913BCE-9B25-4439-8621-728D58DD1396Q34926892-33C5C499-1455-49E0-A769-5A3A49C2AADDQ35095179-CDA7EEA5-7229-4E51-B2B9-3E7EDFA7BC3DQ35143961-99F2FCD5-DB33-4744-A72D-DAB5CC6880F1Q35439268-004310B4-D83D-40E1-A748-440827FC8AF4Q35639110-0C1413CC-0AA8-48EA-B7B9-C60E86919E29Q35762249-50B3D8B8-DB9F-45D7-98DA-7DFBE1536668Q35847242-C2A45765-8948-4B43-9CA3-C2CB9ADF709FQ36254665-247686FF-A332-4DEE-A337-2A0387A60F24Q36329558-B43F66C3-580B-4C01-A223-DD04FA6722CBQ36490198-AD468E3C-8514-431C-B7A2-B78F3382FCF4Q36998336-AF900CB6-229D-4E6D-B840-1B46CF5E6683Q37168123-DAD11853-4EE2-4585-ADD7-CB68DE14CBD7Q37186130-7A38ACF4-B295-4A67-96D2-497FC04E025AQ37262946-C1633F57-FAA2-4DF8-8CF9-FB14BA38746BQ37309361-A622BCFC-6FAB-4FBD-9DF5-2642ACF73D46Q37341158-7FFCB08D-3F3B-4008-A2C5-380437C60B0E
P2860
Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy.
@en
Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy.
@nl
type
label
Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy.
@en
Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy.
@nl
prefLabel
Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy.
@en
Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy.
@nl
P2093
P1476
Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy.
@en
P2093
D Gladstone
H A Gardner
R Gladstone
R Weksberg
T Einarson
P304
P356
10.1001/JAMA.1994.03510340057034
P407
P577
1994-03-01T00:00:00Z